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Basolateral transport of organic anions (OAs) into mammalian renal proximal tubule cells is a tertiary active transport process. The final
step in this process involves movement of OA into the cells against its electrochemical gradient in exchange for a-ketoglutarate (aKG)
moving down its electrochemical gradient. Two homologous transport proteins (OAT1 and OAT3) that function as basolateral OA/aKG
exchangers have been cloned and sequenced. We are in the process of determining the functional distribution and regulation of OAT1 and
OAT3 in renal tubules. We are using rabbit OAT1 (rbOAT1) and OAT3 (rbOAT3) expressed in heterologous cell systems to determine
substrate specificity and putative regulatory steps and isolated rabbit proximal renal tubule segments to determine functional distribution and
physiological regulation of these transporters within their native epithelium. Rabbit OAT1 and OAT3 differ distinctly in substrate specificity.
For example, rbOAT1 has a high affinity for the classical renal OA transport substrate, p-aminohippurate (PAH), whereas rbOAT3 has no
affinity for PAH. In contrast, rbOAT3 has a high affinity for estrone sulfate (ES), whereas rbOAT1 has only a very slight affinity for ES. Both
rbOAT1 and rbOAT3 appear to have about the same affinity for fluorescein (FL). These differences and similarities in substrate affinities
make it possible to functionally map transporters along the renal tubules. Initial data indicate that OAT1 predominates in S2 segments of the
rabbit proximal tubules, but studies of other segments are just beginning. Transport of a given substrate in any tubule segment depends on
both the affinity of each transporter which can accept that substrate as well as the level of expression of each of those processes in that
particular tubule segment. Basolateral PAH transport (presumably OAT1 activity) appears to be down-regulated by activation of protein
kinase C (PKC) and up-regulated via mitogen-activated protein kinase (MAPK) through phospholipase A2 (PLA2), prostaglandin E2 (PGE2),
cyclic AMP, and protein kinase A (PKA) activation.
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1. Introduction [1,2], including many of the products of Phase I and PhaseA large and diverse number of organic anions, or weak
organic acids that exist as anions at physiological pH
(collectively OAs), are secreted by mammalian renal tubules
[1,2]. Substrates for the renal OA transport system include
weak acids that have a net negative charge on carboxyl or
sulfonyl residues at physiological pH. Although a number of
endogenous OAs have been shown to be actively secreted
by the proximal tubule (e.g., 5V-hydroxyindoleacetic acid,
riboflavin), it is generally accepted that the principal func-
tion of this process is clearing the body of xenobiotic agents0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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E-mail address: dantzler@u.arizona.edu (W.H. Dantzler).II hepatic biotransformation, as well as anionic drugs of
therapeutic or recreational use [3–5].
Classical studies with isolated rabbit renal proximal
tubules that examined the axial tubular distribution of
secretion of the prototypical OA, p-aminohippurate (PAH),
indicated that the S2 segment of the proximal tubule is the
primary tubule site of OA excretion, although net PAH
secretion certainly occurs in both the S1 and S3 segments
[6–8]. Most kinetic studies with single tubules suggest that
the difference in transport between these segments reflects a
difference in the number of transporters per unit length
rather than a difference in specific transporters [8,9]. How-
ever, some studies with transport inhibitors suggest that
there might yet be some difference in the characteristics of
the transporters between the S2 and S3 segments [8].
Different transporters with different substrate specificities
  
Fig. 1. Simplified descriptive model of transepithelial transport of OAs in
proximal renal tubules. Transport of OA into cells at basolateral membrane
involves a tertiary active transport process (three transport steps functioning
in parallel). Solid arrows indicate transport against an electrochemical
gradient. Broken arrows indicate transport down an electrochemical
gradient. Question mark indicates uncertainty about nature of transporter.
OA stands for any Type I organic anion transported by the classical
pathway. aKG2 stands for a-ketoglutarate. (1) OA/aKG2 countertran-
sport step, the final step in the tertiary active transport process that moves
OA into cells. Molecular candidates for this step are OAT1 and OAT3. (2)
Na+-DC cotransport step that moves aKG2 into cells. The primary
molecular candidate for this step is Na-DC3. (3) Na+-K+-ATPase, the
primary energy-requiring transport step that establishes and maintains the
Na+-gradient that drives step 2.
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tant in the kidney’s ability to excrete specific xenobiotic
agents under pathological conditions. They could also play a
role in determining which segments are affected most by a
given nephrotoxic xenobiotic agent. We now know that this
is a much more likely possibility than previously thought
(see below).
The transepithelial secretory process involves OA trans-
port into the cells against an electrochemical gradient across
the basolateral membrane and transport from the cells into
the tubule lumen down an electrochemical gradient across
the luminal membrane. Until recently, models of renal OA
secretion typically depicted a single basolateral entry step
and a single luminal exit step, a simple view that effectively
explained existing physiological data. That view is now
known to be an oversimplification of the suite of cellular
events that underlies renal OA transport. At least two broad
general secretory pathways can be recognized based on
selectivities for two general substrate classes defined on
the basis of molecular weight, net charge, and hydropho-
bicity. Adapting the classification scheme used to function-
ally categorize organic cation transporters [10], we will refer
to the first group as the one handling ‘Type I’ OAs, which
includes comparatively small (generally < 400 MW) mono-
valent compounds, including PAH, probenecid, and fluo-
rescein (FL). These are transported by what has been
referred to as the ‘‘classical’’ OA secretory pathway. The
second group of compounds (‘Type II’ OAs) is generally
bulkier (typically >500 MW) and frequently polyvalent.
They include, for example, leukotriene C4 and estradiol-
17h-D-glucoronide (E17h-D). We are concerned in this
paper only with the ‘‘classical’’ pathway and the transport
of ‘‘Type I’’ OAs. However, this pathway alone involves
multiple transporters that can be functionally distinguished,
at least in part, on the basis of the substrates with which they
most efficiently interact (see below). The tubule location
and regulation of these different transporters is likely to play
a critical role in the excretion of specific xenobiotics under
various physiological and pathological conditions.
The basolateral entry step for Type I OAs via the
‘‘classical’’ pathway is against an electrochemical gradient
and, thus, involves an active, energy-requiring process.
Initial studies with rat basolateral membrane vesicles
[11–13] followed by studies with intact rabbit proximal
tubules [14] convincingly demonstrated that the basolateral
step in the ‘‘classical’’ pathway involves a tertiary active
transport process (three basolateral transport processes
arranged in parallel) (Fig. 1). The final step in the overall
process is the countertransport of the OA (e.g., PAH or FL)
into the cell against its electrochemical gradient in ex-
change for an intracellular dicarboxylate (physiologically,
a-ketoglutarate (aKG)) moving down its electrochemical
gradient (Fig. 1). The outwardly directed gradient for aKG
is maintained in turn by metabolism (f 40%) and by
transport into the cells across both the basolateral and
luminal membranes by the activity of Na+-dicarboxylate(Na-DC) cotransporters (f 60%) [15,16] (Fig. 1). The
inwardly directed Na+-gradient driving this process is
maintained by the primary energy-requiring transport step
in the process, the transport of Na+ out of the cells by Na+-
K+-ATPase at the basolateral membrane (Fig. 1). Molecular
candidates for each of these processes have been cloned.
However, in this paper, we are concerned only with the
basolateral OA/aKG exchange step, the critical final step in
getting OAs into the cells across the basolateral membrane.
We are primarily interested in determining the tubular
distribution, relative functional significance, and regulation
of the molecular candidates for this transport step. It is
imperative that the functional distribution and regulation of
these molecular transporters be determined within a native
intact renal tubule epithelium. Among mammalian proxi-
mal tubules, only those from rabbit kidneys can be readily
teased out without the aid of enzymatic agents for these
determinations. Therefore, we have also cloned and begun
characterizing the molecular candidates for this transport
step from rabbit renal tissue (see below). We review our
progress to date in these studies.
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The basolateral OA/aKG transporter appears to involve
(at least) two distinct processes: OAT1 and OAT3. Two
homologous transporters have been identified and also local-
ized to the kidney (OAT2 and OAT4), but their roles in renal
OA transport remain speculative. OAT1was first cloned from
rat kidney and functionally identified as an organic anion
transporter in 1997 by two independent groups (OAT1 [17];
ROAT1 [18]). It proved to be the rat ortholog of a protein first
cloned from mouse kidney, originally named NKT, for which
no function was identified [19]. In addition to rat and mouse
OAT1, orthologs have been cloned from human [20–23],
flounder [24], and C. elegans [25], and recently from rabbit
by us [26]. The mammalian orthologs display approximately
80% sequence identity with one another. The cDNAs for the
four cloned mammalian OAT1s have open reading frames
that code for proteins that range from 545 to 551 amino acids
in length. Strong sequence homology with a group of
previously cloned organic cation transporters led to the
combined classification of the entire group of ‘OCTs’ and
‘OATs’ into a common family of transport proteins collec-
tively referred to as the Organic Cation Family of transporters
(alternatively referred to as the Amphiphilic Solute Facilitator
Family [27]) that are, in turn, classified within the larger
Major Facilitator Superfamily of transporters [28]. Con-
served motifs within all OAT1 orthologs include three protein
kinase C (PKC) consensus sites; and as many as five
consensus sites for protein kinase A (PKA). Because we are
working with isolated rabbit proximal tubules (as the standard
model for studies of integrated function in isolated intact
tubules because human tubules are not routinely available),
we are concerned primarily with the rabbit OAT1 (rbOAT1).
OAT3 was also initially cloned from rat kidney, and its
cDNA was found to encode for a protein 536 amino acids
long [29]. Two OAT3 orthologs have been cloned from
human kidney, only one of which supports OA transport
[22,30]. This ortholog, hOAT3, codes for a 543 amino acid
protein [30]. We have now cloned the rabbit ortholog
(rbOAT3), the cDNA for which encodes for a 542 amino
acid protein that shows 85% and 82% identity to the human
and rat orthologs, respectively.
The general secondary structure of the OCT family of
transporters, including OAT1 and OAT3, shows 12 trans-
membrane domains (TMD), intracellular N- and C-termini,
a very long extracellular loop between TMD1 and TMD2
(which typically includes three to four N-linked glycosyla-
tion sites), and a long intracellular loop between TMD6 and
TMD7. As noted above, all members of the family also have
various numbers of PKC and PKA consensus sites.
The tubular distribution of OAT1 and OAT3 is far from
clear. Immunocytochemical studies in rats suggest that
OAT1 is located primarily in the basolateral membrane of
cells in the S2 segment, although it is also found in the S1
and S3 segments [31,32]. This distribution is consistent with
the previous physiological data on rabbit tubules showingthe greatest PAH secretion in the S2 segment [6–8], but no
direct quantitative information on functional distribution of
OAT1 is available for these or any other renal tubules.
Immunocytochemical data on human and rat kidneys sug-
gest that OAT3 is expressed at the basolateral membrane of
S1, S2, and S3 segments of the proximal tubule [31–33]. In
the human kidney, expression levels in the proximal tubule
appear to be in the order S1>S2 = S3 [31]. Again, however,
no quantitative functional data on the distribution of this
transporter are available. As indicated above, we are now in
the process of determining the functional distribution and
regulation of OAT1 and OAT3, the two known molecular
candidates for the OA/aKG exchanger, in rabbit proximal
renal tubules.3. Substrate-specificity of OAT1 and OAT3
We have been comparing the substrate-specificity and
transport characteristics of rbOAT1 and rbOAT3 with the
two transporters expressed both artificially in heterologous
expression systems and naturally in intact, isolated S2
segments of rabbit proximal renal tubules. For these studies,
we transiently expressed rbOAT1 in COS7 cells and stably
expressed rbOAT3 in CHO-K1 cells.
3.1. OAT1
We determined the kinetics of PAH transport by rbOAT1
by measuring radiolabeled PAH uptake into COS7 cells
expressing rbOAT1 at increasing concentrations of unla-
beled PAH [26]. PAH uptake was nearly linear for 2 min and
that incubation time was used to provide an estimate of the
initial rate of transport. As shown in Fig. 2, PAH transport
saturated with a Kt of f 16 AM. To compare PAH transport
by isolated rbOAT1 with transport by this process in its
native intact epithelium, we made similar kinetic measure-
ments of radiolabeled PAH uptake in isolated S2 segments
of rabbit proximal tubules. The kinetics in the isolated
tubules were similar to those seen in the COS7 cells
expressing the transporter but the Kt was about four times
higher (f 70 AM) (Fig. 2). This difference in the Kts
between the two systems could reflect functional differences
in the ‘transport environment’ of the two cell types in
question (e.g., different regulatory profiles or the influence
of unstirred layers on substrate availability in the intact
tubule); or the potential influence of PAH interaction with
additional transporters, including OAT3 transporter (but see
below).
To be certain that the cloned transporter, rbOAT1, when
expressed in COS7 cells actually functioned as an OA/aKG
exchanger, we preloaded the transfected COS7 cells with
glutarate (which can substitute for aKG in the exchange
process) and measured the uptake of FL in real time. As
shown in Fig. 3, preloading the cells with glutarate more
than doubled the initial rate of FL uptake. Essentially, this is
Fig. 2. (A) Kinetics of PAH transport by rbOAT1 expressed in COS7 cells.
Uptake of radiolabeled PAH ([3H]PAH) (0.2 AM) on ordinate vs.
concentration of unlabeled PAH in bathing medium on abscissa. Values
are meansF S.E. n= 3 experiments. Solid circles represent transport in
transfected cells; open circles represent transport in non-transfected cells.
Figure is redrawn with modifications from Ref. [26]. (B) Kinetics of PAH
transport by S2 segments of rabbit proximal renal tubules. Uptake of
radiolabeled PAH ([3H]PAH) (6 AM) on ordinate vs. concentration of
unlabeled PAH in bathing medium on abscissa. Values are meansF S.E.
n= 3 tubules. Symbols are the same as in A. Preliminary unpublished data
from A. Lungkaphin.
Fig. 3. Left-hand panel. FL (1 AM) uptake as percentage of control (with
control being 100%) by rbOAT1 expressed in COS7 cells before (control)
and after preloading (trans condition) with glutarate or urate. Bars represent
meansF S.E. n= 3 experiments. Figure is redrawn with modifications from
Ref. [16]. Right-hand panel. FL (1 AM) uptake as a percentage of control
(with control being 100%) in the absence (control) and presence of 10 AM
aKG. Symbols are the same as in the left-hand panel. n= 18 tubules.
Redrawn with modifications from Ref. [15].
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isolated rabbit S2 segments were exposed to aKG in the
bathing medium (Fig. 3) [15]. The uptake of aKG by the
Na-DC cotransporter is sufficiently rapid in the intact tubule
that the stimulation of the initial rate of FL uptake via the
OA/aKG exchanger occurs within about 5 s of exposure to
physiological levels of aKG (10 AM; Fig. 4) [15]. As shown
in Fig. 3, we also determined the effect of preloading the
rbOAT1-transfected COS7 cells with urate on the initial rate
of FL uptake. Our reason for doing this was that rabbit
proximal tubules show net secretion of urate and there was
some evidence that such secretion might involve the ‘‘clas-
sical’’ OA secretory pathway [34]. If so, it should showcountertransport for FL. However, as shown in Fig. 3,
preloading the COS7 cells with urate had no effect on FL
uptake. Thus, the cloned rbOAT1 transporter, at least as
expressed in a heterologous system, does not appear to
support a substantial rate of urate transport.
3.2. OAT3
In examining the cloned rbOAT3, we not only considered
possible transport of PAH but also the transport of estrone
sulfate (ES), which has been shown to interact with cloned
OAT3 from other species (e.g., [35]). Initially, we simply
examined the degree of uptake of these substrates by
rbOAT3-transfected CHO cells compared to wild-type
CHO cells. As shown in Fig. 5, rbOAT3 expressed in CHO
cells, unlike rbOAT1 expressed in COS7 cells, had almost no
ability to transport PAH. However, it readily transported
radiolabeled ES and this transport was completely inhibited
by a high concentration of unlabeled ES (Fig. 5). Preliminary
data now indicate that rbOAT1 expressed in COS7 does
support modest ES transport, but the affinity of rbOAT1 for
ES is comparatively quite low. Thus, these two rabbit trans-
porters have strikingly different substrate selectivities, at least
when expressed in heterologous systems. In addition,
rbOAT3 expressed in CHO cells readily transported cimeti-
dine (Fig. 5). This is interesting because cimetidine appears
capable of being transported by both the organic anion and
the organic cation transport systems (e.g., Ref. [36]), and this
observation suggests that renal secretion by the ‘‘classical’’
organic cation pathway may involve interaction with OAT3,
in rabbits at least.
Fig. 4. Fluorescence record showing stimulation of FL uptake into an S2
segment of rabbit proximal renal tubule resulting from an acute cis-
exposure to 1 AM FL plus 10 AM aKG and blockage of that cis-stimulation
by simultaneous exposure to 2 mM Li+ (which blocks aKG uptake by the
Na+-DC cotransporter). FL uptake is expressed in terms of photomultiplier
output. Fluorescence output prior to t = 0 (period labeled ‘‘No FL’’) reflects
autofluorescence of tubule. At time 0, superfusion buffer was switched to
one containing 1 AM FL. In all measurements, there was a rapid increase in
fluorescence (tof 450,000 photons/s) due to the addition of FL and a
subsequent slower increase in fluorescence from the accumulation of FL in
the tubule. Each point is meansF S.E of three determinations of FL uptake
(where error bars are not evident, the error was smaller than the graphic
representation of the mean). Solid lines are linear regressions determined
from increases in fluorescence between t = 5 s and t = 25 s. From Ref. [15]
with permission.
Fig. 5. Uptake of radiolabeled PAH ([3H]PAH) (0.25 AM), cimetidine
([3H]CIM) (0.10 AM), and estrone sulfate ([3H]ES) (0.023 AM) and effects
of high concentrations of unlabeled substrates on it by rbOAT3 expressed in
CHO cells. Data shown are multiples of uptake by wild-type CHO cells.
Bars represent mean of three experiments. Preliminary unpublished data
from X. Zhang.
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for rbOAT3, we examined the kinetics of its transport, first
by determining the uptake of radiolabeled ES by CHO cells
expressing rbOAT3 with increasing concentrations of unla-
beled ES and second by making similar determinations with
isolated rabbit S2 proximal tubule segments with increasing
concentrations of unlabeled ES. As shown in Fig. 6, ES
transport saturated with a Kt of f 4 AM that, unlike the Kt
for PAH transport by rbOAT1, was the same for ES
transport by rbOAT3 expressed in CHO cells and in intact,
rabbit proximal S2 tubules.
For rbOAT3, it was particularly important to determine
that the transport we were observing involved OA/aKG
countertransport because only recently has OAT3 from anyFig. 6. (A) Kinetics of ES transport by rbOAT3 expressed in CHO cells.
Uptake of radiolabeled ES ([3H]ES) (0.023 AM) on ordinate vs.
concentration of unlabeled ES in bathing medium on abscissa. Values are
means from three wells from a single experiment. Unpublished data from
X. Zhang. (B) Kinetics of ES transport by S2 segments of rabbit proximal
renal tubules. Uptake of radiolabeled ES ([3H]ES) (1 AM) on ordinate vs.
concentration of unlabeled ES in bathing medium on abscissa. Values are
meansF S.E. n = 3 tubules. Preliminary unpublished data from A.
Lungkaphin.
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For this purpose, we measured the initial rate of uptake of
radiolabeled ES by CHO cells expressing rbOAT3 and
isolated rabbit proximal S2 segments under control circum-
stances and when each preparation was preloaded with
glutarate (as a non-metabolized surrogate for aKG). As
shown in Fig. 7, preloading with glutarate led to a doubling
of the rate of ES uptake in both the CHO cells and proximal
S2 segments, thereby demonstrating that rbOAT3 can func-
tion as an appropriate countertransporter for the final step in
the ‘‘classical’’ tertiary active OA transport pathway across
the basolateral membrane (Fig. 1).
Of additional interest, preloading CHO cells expressing
rbOAT3 with urate stimulated uptake of radiolabeled ES
even more effectively than preloading the cells with gluta-
rate (Fig. 7). These data indicate that urate can be trans-
ported by rbOAT3 and this appears to be confirmed by
recent preliminary studies on direct transport of radiolabeled
urate by rbOAT3 expressed in CHO cells.
3.3. Summary comparison of function of rbOAT1 and
rbOAT3
Based on our studies to date, both rbOAT1 and rbOAT3
can function as OA/aKG countertransporters in the ‘‘clas-
sical’’ tertiary active pathway for transport of OAs across
the basolateral membrane of the renal tubules (Fig. 1).
However, the substrate specificity of these two transporters
appears to be strikingly different. Whereas rbOAT1 readily
transports PAH and barely transports ES, rbOAT3 avidly
transports ES and effectively has no interaction with PAH.
This appears to be the case not only when these transporters
are artificially expressed in heterologous systems, but also
when they are naturally expressed in intact, isolated S2Fig. 7. Left-hand panel. Radiolabeled ES ([3H]ES) (0.023 AM) uptake as a
percentage of control (with control being 100%) by rbOAT3 expressed in
CHO cells before (control) and after preloading (trans condition) for 15 min
with glutarate (500 AM) or urate (1 mM). Bars represent mean of three
wells from a single experiment. Preliminary unpublished data from X.
Zhang. Right-hand panel. Radiolabeled ES ([3H]ES) (1 AM) in suspension
of rabbit proximal renal tubules as a percentage of control (with control
being 100%) before (control) and after preloading for 15 min with 500 AM
glutarate. Bars represent meansF S.E. of duplicate of a single experiment.
Preliminary unpublished data from C. Groves.segments of rabbit proximal tubules. Indeed, we have
compared the inhibition of radiolabeled PAH transport by
unlabeled ES and radiolabeled ES transport by unlabeled
PAH in these isolated tubule segments. In these studies, the
ratio of the IC50 for ES inhibition of PAH transport to the Kt
for ES transport was f 25 and the ratio of the IC50 for PAH
inhibition of ES transport to the Kt for PAH transport was
~12. If the transport pathways for these two substrates
involved any significant interaction, these ratios should have
been close to 1.0. Therefore, it appears that in the S2
segment of the rabbit proximal tubule PAH is transported
by a process (presumably OAT1) different from that for ES
(presumably OAT3).
Moreover, the affinity of rbOAT3 for ES is substantially
greater than that of rbOAT1 for PAH (Figs. 2 and 6). And
the difference between the Kts for PAH interaction with
rbOAT1 in COS7 cells and in proximal S2 segments (Fig. 2)
cannot be explained by interaction with rbOAT3 in the
tubule segments. It is also of interest that our current
preliminary data suggest that secretion of urate and cimet-
idine by S2 segments of rabbit proximal tubules may
involve primarily OAT3, not OAT1. However, it is also
becoming apparent that these two transporters do not
necessarily have different affinities for all substrates. For
example, preliminary data with the transporters in heterol-
ogous expression systems and in S2 segments of rabbit
proximal tubules suggest that both transporters have about
the same affinity for FL.
The combination of the differences and similarities in
substrate affinities now make it possible to functionally map
the transporters along the proximal tubule. At present, we
have only begun this process with the S2 segment of the
rabbit proximal tubule. This is the segment that, on the basis
of PAH transport, has been considered to be the primary site
of OA secretion in the mammalian renal tubules [6–8].
Indeed, it clearly does transport PAH via OAT1. Moreover,
the observation that the Jmax for basolateral uptake of
radiolabeled PAH by rabbit S2 proximal segments is about
12 times the Jmax for basolateral uptake of radiolabeled ES
by these same segments (Figs. 2 and 6) suggests that there
are more OAT1 transporters than OAT3 transporters in this
segment. However, this requires further study, as do the
transport properties of the S1 and S3 segments. In any case,
our current data suggest that the transport of a given
substrate in any tubule segment depends on both the affinity
of each transporter that can accept that substrate as well as
the level of expression of each of those processes in that
particular tubule segment.4. Regulation of basolateral organic anion transport
Although regulation of the basolateral exchanger can be
examined with cloned transporters expressed in heterolo-
gous systems, it is not possible to know whether apparent
regulation under these circumstances reflects the situation
Fig. 8. Radiolabeled PAH ([3H]PAH) (6 AM) uptake as a percentage of
control (with control being 100%) by S2 segments of rabbit proximal
tubules. Bars represent meansF S.E. for 12 tubules for EGF and U0126
data and 8 tubules for PGE2 and H89 data. Treatments are shown below
bars. Preliminary unpublished data from W.H. Dantzler.
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environment within an intact epithelium. Therefore, we are
in the process of determining regulation within intact,
isolated proximal tubule segments. However, only within
the past year has it been recognized that OAT3 as well as
OAT1 can function as the basolateral exchanger within the
intact renal tubule and that the substrate specificities of these
two transporters differ (see above) [3,35]. Therefore, much
of our work (and that of others) did not take the possibility
of two transporters into account. Indeed, by the middle
1990s, even before OAT1 was cloned and found to have
consensus sites for phosphorylation by PKC (thereby mak-
ing it a potential target for regulation via pathways involv-
ing activation of PKC; see above), a few studies with both
mammalian and non-mammalian cells and tubules sug-
gested that phosphorylation via PKC could be important
[37–39]. Although most data suggested that activation of
PKC depressed OA transport, there were some discrepan-
cies in the data. We re-evaluated and extended these
observations by examining both the initial rate of uptake
and transepithelial transport of FL in real time with isolated
non-perfused and perfused S2 segments of rabbit proximal
tubules [40,41]. Our data indicate that activation of PKC,
either directly with phorbol 12-myristate 13-acetate (PMA)
or 1,2-dioctanoyl-sn-glycerol (DOG) or indirectly with
ligands of physiological receptors coupled to the PKC
pathway (a1-receptor agonist phenylephrine or peptide
hormone bradykinin), inhibits basolateral FL uptake and
transepithelial transport. This effect is prevented by the
PKC-specific inhibitor bisindolylmaleimide I (BIM). Thus,
in intact S2 segments of rabbit renal tubules, physiological
stimuli can reduce basolateral OA uptake via the PKC
pathway. However, since these studies utilized FL as the
transported substrate, we now know that this down-regula-
tion could have involved OAT1, OAT3, or both. Because
PKC activation has been shown to down-regulate OA
transport by several orthologs of OAT1 expressed in heter-
ologous systems (hOAT1 expressed in HeLa cells [21];
rOAT1 expressed in oocytes [42]; mOAT1 expressed in
LLC-PK1 cells [43]) and by rOAT3 expressed in oocytes
[44], we suspect that down-regulation by PKC-activation in
these intact rabbit S2 proximal segments involves both
OAT1 and OAT3. Nevertheless, this needs to be demon-
strated by studies with intact epithelia involving substrates
specific for each transporter (i.e., PAH and ES).
We, with our collaborators in Wu¨rzburg, Germany,
Michael Gekle and Christoph Sauvant, have continued to
undertake a more detailed evaluation of possible regulation
of basolateral PAH transport by more physiological activa-
tion of regulatory pathways. We have been concentrating on
epidermal growth factor (EGF), which has been suggested
as a mediator of normal tubular growth and tubular regen-
eration after injury. EGF and its receptor are expressed in
rabbit proximal tubule cells [45]. However, the initial
studies involved the effects of EGF on PAH transport by
opossum kidney (OK) cells in culture, a proximal tubule-derived cell line known to demonstrate OA transport and to
contain the mRNA for OAT1 which is simpler to work with
than isolated, individual renal tubules [46]. In this prepara-
tion, Sauvant et al. [46] showed that EGF stimulates baso-
lateral PAH uptake through the mitogen-activated protein
kinase (MAPK) pathway via sequential activation of mito-
gen-activated/extracellular-signal regulated kinase kinase
(MEK) and extracellular signal-regulated kinase isoforms
1 and 2 (ERK1/2). The stimulatory effect of EGF on PAH
uptake is completely blocked by inhibitors of MEK
(PD98059 or U0126). Western blots of OK cell protein
showed phosphorylation of ERK1/2 with EGF administra-
tion that was eliminated by inhibition of MEK, results that
exactly paralleled the effects on PAH transport. Our current
follow-up studies with individual isolated rabbit S2 proxi-
mal tubule segments show an identical pattern for both
inhibition of PAH uptake by U0126 (Fig. 8) and Western
blots of ERK1/2 phosphorylation, except for indicating that
the MAPK pathway apparently also plays a role in the
baseline levels of PAH uptake. Since these studies involved
PAH transport, we know that these steps in up-regulation via
EGF in the intact rabbit S2 segment involve OAT1, but we
do not know if they apply to OAT3. We also do not know if
they apply to the S1 and S3 proximal tubule segments.
Fig. 9. Model of apparent regulatory cascade for stimulation of organic
anion transport by EGF. Abbreviations: mitogen-activated/extracellular-
signal regulated kinase kinase (MEK); extracellular-signal regulated kinase
isoforms 1 and 2 (ERK1/2); phospholipase A2 (PLA2); arachidonic acid
(AA); cyclooxygenase 1 (COX1); prostaglandin E2 (PGE2); protein kinase
A (PKA). Other symbols are the same as in Fig. 1. Question mark indicates
uncertainty about application to OAT3.
W.H. Dantzler, S.H. Wright / Biochimica et Biophysica Acta 1618 (2003) 185–193192We are extending these studies to investigate the regu-
latory network of EGF action on PAH uptake downstream
of ERK1/2 in more detail. The initial studies again in-
volved OK cells in culture [47]. Using a series of inhibitors
and an assay for arachidonic acid release, Sauvant et al.
concluded that EGF successively activates MEK, ERK1/2,
and phospholipase A2 (PLA2), leading to an increased
release of arachidonic acid. Subsequently, arachidonic acid
is metabolized to prostaglandins via cyclooxygenase 1
(COX1), which then mediate EGF-induced stimulation of
basolateral PAH uptake. Additional preliminary studies
indicate that prostaglandin E2 (PGE2) stimulates basolateral
PAH uptake in OK cells via adenylate cyclase activation
and subsequent PKA activation (C. Sauvant and M. Gekle,
personal communication). We are continuing these studies
with isolated rabbit S2 proximal tubule segments, in which
we find that PGE2 also stimulates basolateral PAH uptake
and that this stimulation is prevented by the PKA inhibitor
H89 (Fig. 8). Thus, this cascade apparently functions in
intact S2 segments of rabbit proximal tubules (see summary
in Fig. 9). As discussed above, transport of PAH by rabbit
tubules probably reflects activity of OAT1. There is cur-
rently no evidence concerning the influence of activation of
the MAPK signaling cascade on activity of OAT3. More-
over, we have no idea whether this regulatory cascade
applies to the S1 and S2 proximal segments. Studies with
transporter-specific substrates (e.g., PAH and ES for OAT1
and OAT3, respectively) and all three tubule segments are
needed to resolve this situation. Knowledge of the extent to
which regulation of OAT1 and OAT3 activity influences
the profile of renal organic anion secretion in intact renal
proximal tubules is critical to understanding the regulationof the basolateral transport of both toxic and therapeutic
xenobiotics.
Finally, it must be noted that despite the presence of PKC
and PKA phosphorylation sites on the OAT1 and OAT3
transporters, it is not certain that either down-regulation
through PKC activation or up-regulation through PKA
activation actually involves phosphorylation of the trans-
porters. Indeed, in the only study to date to examine this
issue, activation of PKC in LLC-PK1 cells that stably
expressed mouse OAT1 did not result in phosphorylation
of OAT1 protein. The decrease in PAH uptake that followed
activation of PKC in these cells was associated with a
decrease in Jmax, with no change in Kt. These observations
led to the suggestion that activation of PKC may increase
internalization of membrane transporters, or inhibit recruit-
ment of preformed transporters from a cytoplasmic pool
[43]. Similar kinetics (reduction of Jmax with no change in
Kt) are seen for the inhibition of the activity of heterolo-
gously expressed rOAT3 by PKC activation [44], and this
may be the case in the intact renal tubules.Acknowledgements
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